This article previews some formulation topics discussed in the Pharma Fundamentals series, which aims to enhance learning for professionals in pharmaceutical drug development and manufacturing. It is ...
In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...
Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...
CAMBRIDGE, MA -- About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
Firms will offer integrated solutions for multiparticulate oral controlled-release products. Drug formulation and delivery specialists Bend Research and Catalent Pharma Solutions inked an agreement to ...
Hosted on MSN
India raising the bar on drug formulation challenges
India has long been hailed as the pharmacy of the world, thanks to its robust generics sector and formidable manufacturing capabilities. Today, the Indian pharmaceutical industry is poised to leverage ...
The Company's revenue streams include sales and royalty revenues from CRINONE® 8% (progesterone gel), which is marketed by Actavis, Inc. in the United States and by Merck Serono S.A. in over 60 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results